Home › Trials › NCT04714918

Survey on the prevalence of Chronic Kidney Disease-Mineral and Bone Disorder in China

Chinese Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD) Prevalence Survey

Observational Peking Union Medical College Hospital · NCT04714918

This study is trying to find out how common Chronic Kidney Disease-Mineral and Bone Disorder is among people in China by collecting health information from over 9,800 patients in different hospitals.

Quick facts

Study typeObservational
Enrollment10254 (estimated)
SexAll
SponsorPeking Union Medical College Hospital Academic / other
Locations40 sites (Beijing, Beijing and 39 other locations)
Trial IDNCT04714918 on ClinicalTrials.gov

What this trial studies

This observational study aims to investigate the prevalence of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD) among the Chinese population. It will utilize a multi-center cross-sectional epidemiological approach, collecting data from over 9,800 subjects across various hospitals in China. A questionnaire will gather demographic information, medical history, laboratory test results, and medication details. The study will employ a multistage stratified cluster sampling method to ensure a representative sample from different geographic regions.

Who should consider this trial

Good fit: Ideal candidates for this study include individuals with kidney damage for at least three months and specific criteria related to glomerular filtration rate or proteinuria.

Not a fit: Patients without available test results or medical history within the last three months may not benefit from this study.

Why it matters

Potential benefit: If successful, this study could provide critical insights into the prevalence of CKD-MBD, potentially leading to improved management and treatment strategies for affected patients.

How similar studies have performed: While similar epidemiological studies have been conducted globally, this specific investigation into CKD-MBD prevalence in the Chinese population is novel.

Eligibility criteria

Show full inclusion / exclusion criteria 
Inclusion Criteria:

* Kidney damage for ≥ 3 months, and one of the following criteria:

  1. Glomerular filtration rate (GFR) \<60 mL/min/1.73m2 for 3 months or more, irrespective of cause.
  2. proteinuria (\>30 mg of urinary albumin excretion per gram of urinary creatinine, \> 50 mg of urinary protein excretion per gram of urinary creatinine, \>1+ for proteinuria in dipstick, \> 0.3g of 24 hour urine protein)
  3. structural renal abnormalities
* hospitalized patients not on dialysis or dialysis patients followed regularly in Hemodialysis centers or Peritoneal Dialysis centers

Exclusion Criteria:

* no available test results within 3 months prior to this study
* no available information of medication or past medical history

Where this trial is running

Beijing, Beijing and 39 other locations

Study contacts

How to participate

  1. Review the eligibility criteria above with your treating physician.
  2. Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
  3. Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
View on ClinicalTrials.gov → Find more trials like this →
Conditions Chronic Kidney DiseasesChronic Kidney Disease-Mineral and Bone DisorderHypocalcemiaHyperphosphatemiaSecondary Hyperparathyroidism
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.